$IBM

IBM just had its worst day ever. Oppenheimer thinks investors should stay away from the stock

Oppenheimer downgraded IBM to Perform from Outperform, saying the bull case will take longer and the stock may be range bound. The firm cited preliminary Q2 results: adjusted EPS $2.93 on revenue $17.2B, below FactSet estimates ($3.01, $17.86B). IBM shares fell about 25% to their worst day ever, with full results due July 22.

Original reporting
Published Jul 15, 2026, 11:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 11:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IBM just had its worst day ever. Oppenheimer thinks investors should stay away from the stock — source image
Decision brief

The 30-second read

$IBMBearishMed
01

Why it matters

A same-day analyst downgrade following a large selloff increases the probability of further downgrades and keeps traders focused on whether IBM can close the gap to full-year objectives.

02

Market read

Traders get a concrete catalyst (downgrade) tied to a specific earnings miss and a near-term catalyst (July 22 full report).

03

What to watch

The piece relies on preliminary Q2 numbers and Oppenheimer’s view on full-year guide; actual management commentary and segment-level trends on July 22 could change the risk outlook.

Relevance 8/10Novelty 6/10Timing: post-preliminary Q2 selloff, ahead of the July 22 full earnings report

Background

IBM is approaching its full Q2 earnings release on July 22 after reporting preliminary adjusted EPS and revenue that fell short of consensus.

Company-level read

Ticker impact

$IBMBearishHigh confidence
Context

Oppenheimer downgraded IBM to Perform after preliminary Q2 results missed consensus on EPS and revenue, with shares down 25% Tuesday.

Expected impact

Bearish bias for the next several sessions, with elevated volatility into the July 22 full earnings report.

Evidence & confidence

The article cites a same-day 25% plunge and a fresh analyst downgrade explicitly linked to the miss versus FactSet consensus and difficulty meeting guidance.

Market effects

Signals continued pressure on large-enterprise IT spending and software growth expectations, potentially weighing on peers with similar guidance sensitivity.

Primarily US large-cap tech/IT sentiment, with spillover to broader software and infrastructure spending narratives.

Limited direct global impact beyond multinational enterprise IT demand expectations.

Counterpoint

Despite the downgrade, the article notes “bright spots” in Red Hat, HashiCorp, and Confluent, which could support a rebound if the July 22 report clarifies durability of those segments.

Key entities

  • IBM

    Software and hardware company whose preliminary Q2 results missed consensus and was downgraded by Oppenheimer.

  • Oppenheimer

    Issued the downgrade from outperform to perform and argued the bull thesis will take longer to materialize.

  • Param Singh

    Oppenheimer analyst who cited difficulty meeting full-year goals and double-digit CC software growth for CY26/27.

Related articles

$ACNMed

Accenture Acquires IBM Stake in UniCredit Tech Venture

Accenture (NYSE: ACN) will buy IBM’s (NYSE: IBM) majority stake in a joint venture with UniCredit to modernize UniCredit’s IT across 13 European markets. UniCredit will keep a minority stake. Accenture will run operations after closing, while IBM will continue as a technology supplier. Deal is subject to regulatory approvals; no financial terms disclosed.

$IBMMedAI 8/10

Critical RCE in IBM Langflow Triggers CISA Emergency Deadline

CISA added a critical IBM Langflow flaw, CVE-2026-9198 (CVSS 9.8), to its KEV catalog on Aug 4, 2026. Under BOD 26-04, US federal agencies must remediate or disconnect affected systems by Aug 7, 2026, and conduct forensic triage. The unauthenticated RCE chains default endpoints to mint a SUPERUSER token and execute arbitrary Python code. Langflow is part of IBM’s watsonx via DataStax acquisition.

$ACNMed

Accenture Takes Over IBM’s Stake In Technology JV With UniCredit

Accenture (ACN) will buy IBM’s controlling stake in a technology joint venture with UniCredit (UCG) that runs major IT operations for the bank, with UniCredit keeping a minority interest. Accenture will take primary operational responsibility after regulatory approvals and employee consultations. IBM will exit equity but continue as a technology supplier, including IBM Z platforms and software.

$IBMMed

IBM’s Quantum Bet Just Got Bigger—What the HRL Deal Means for Investors

IBM (NYSE:IBM) agreed to acquire HRL Laboratories from Boeing (NYSE:BA) and General Motors (NYSE:GM), adding electron spin qubit expertise to its superconducting-qubit roadmap. IBM said it will invest over $10 billion in quantum over five years and cited US government funding of over $2 billion. The article compares IBM’s valuation (forward P/E ~17.5, P/S 3.1) with Alphabet (26.8, 10.3).

$ACNMed

Accenture buys IBM's stake in UniCredit Tech JV

Accenture will acquire IBM’s 51% stake in V-TServices, a tech JV managing UniCredit’s banking infrastructure across 13 European markets, according to Tech Times and company announcements. Accenture becomes co-owner and operating partner to deliver cloud, data, and AI services. IBM will continue supplying IBM Z platforms pending regulatory approvals.